BioNTech COVID-19 Vaccine Produces 10 Times More Antibodies Than China’s Sinovac: Study

BioNTech COVID-19 Vaccine Produces 10 Times More Antibodies Than China’s Sinovac: Study
A staff member takes a blood for an antibody test in Budapest, Hungary, on July 8, 2021. Laszlo Balogh/AP
|Updated:

A new study by researchers in Hong Kong has found that recipients of BioNTech’s Comirnaty COVID-19 vaccine generate 10 times more antibodies than those who receive the Chinese CoronaVac vaccine made by Sinovac.

The study showed that even after receiving their first BioNTech dose, recipients’ antibody levels were higher than those who had received two doses of Sinovac.
Related Topics